COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 195 filers reported holding COHERUS BIOSCIENCES INC in Q4 2020. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $186,286 | +7.0% | 49,809 | +22.2% | 0.00% | 0.0% |
Q2 2023 | $174,028 | -35.8% | 40,756 | +2.8% | 0.00% | -50.0% |
Q1 2023 | $271,090 | -13.1% | 39,633 | +0.6% | 0.00% | 0.0% |
Q4 2022 | $311,969 | -18.1% | 39,390 | -0.7% | 0.00% | -33.3% |
Q3 2022 | $381,000 | +34.2% | 39,677 | +1.2% | 0.00% | +50.0% |
Q2 2022 | $284,000 | -40.8% | 39,212 | +5.6% | 0.00% | -33.3% |
Q1 2022 | $480,000 | -23.7% | 37,145 | -5.8% | 0.00% | 0.0% |
Q4 2021 | $629,000 | -2.6% | 39,431 | -1.9% | 0.00% | 0.0% |
Q3 2021 | $646,000 | +11.6% | 40,198 | -4.0% | 0.00% | +50.0% |
Q2 2021 | $579,000 | -41.6% | 41,871 | -38.3% | 0.00% | -33.3% |
Q1 2021 | $992,000 | -20.8% | 67,896 | -5.8% | 0.00% | -40.0% |
Q4 2020 | $1,253,000 | +68.9% | 72,080 | +78.3% | 0.01% | +25.0% |
Q3 2020 | $742,000 | +0.7% | 40,429 | -2.0% | 0.00% | 0.0% |
Q2 2020 | $737,000 | +22.6% | 41,247 | +11.3% | 0.00% | +33.3% |
Q1 2020 | $601,000 | -14.9% | 37,043 | -5.5% | 0.00% | 0.0% |
Q4 2019 | $706,000 | -10.9% | 39,184 | +0.3% | 0.00% | 0.0% |
Q3 2019 | $792,000 | -9.0% | 39,084 | -0.7% | 0.00% | 0.0% |
Q2 2019 | $870,000 | +92.5% | 39,357 | +18.9% | 0.00% | +50.0% |
Q1 2019 | $452,000 | +46.3% | 33,103 | -3.1% | 0.00% | +100.0% |
Q4 2018 | $309,000 | -45.6% | 34,175 | -0.8% | 0.00% | -50.0% |
Q3 2018 | $568,000 | +33.0% | 34,438 | +12.9% | 0.00% | +100.0% |
Q2 2018 | $427,000 | +52.5% | 30,497 | +20.4% | 0.00% | 0.0% |
Q1 2018 | $280,000 | +23.3% | 25,321 | -2.0% | 0.00% | 0.0% |
Q4 2017 | $227,000 | -33.8% | 25,838 | +0.5% | 0.00% | 0.0% |
Q3 2017 | $343,000 | +0.6% | 25,715 | +8.1% | 0.00% | 0.0% |
Q2 2017 | $341,000 | -21.4% | 23,793 | +16.0% | 0.00% | -50.0% |
Q1 2017 | $434,000 | -9.0% | 20,513 | +21.0% | 0.00% | 0.0% |
Q4 2016 | $477,000 | -99.9% | 16,959 | -0.3% | 0.00% | 0.0% |
Q3 2016 | $455,340,000 | +58.8% | 17,003 | +0.2% | 0.00% | +100.0% |
Q2 2016 | $286,742,000 | -2.1% | 16,977 | +22.9% | 0.00% | 0.0% |
Q1 2016 | $293,000,000 | -7.6% | 13,811 | 0.0% | 0.00% | 0.0% |
Q4 2015 | $317,000,000 | +114340.4% | 13,811 | -0.2% | 0.00% | 0.0% |
Q3 2015 | $277,000 | -99.9% | 13,835 | +0.1% | 0.00% | -50.0% |
Q2 2015 | $399,369,000 | +205.3% | 13,819 | +223.0% | 0.00% | +100.0% |
Q1 2015 | $130,821,000 | +87.4% | 4,278 | 0.0% | 0.00% | – |
Q4 2014 | $69,817,000 | – | 4,278 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Atlas Venture Associates IX, LLC | 568,408 | $2,125,846 | 18.08% |
CM Management, LLC | 548,000 | $2,049,520 | 2.18% |
AlphaCentric Advisors LLC | 912,500 | $3,412,750 | 1.94% |
Knott David M Jr | 630,000 | $2,356 | 0.90% |
COURAGE CAPITAL MANAGEMENT LLC | 50,000 | $187 | 0.63% |
Bridge City Capital, LLC | 276,224 | $1,033,078 | 0.52% |
Kohlberg Kravis Roberts & Co. L.P. | 3,036,076 | $11,354,924 | 0.40% |
Ikarian Capital, LLC | 865,787 | $3,238,043 | 0.39% |
Aristotle Capital Boston, LLC | 2,342,977 | $8,762,734 | 0.28% |
TANG CAPITAL MANAGEMENT LLC | 400,000 | $1,496,000 | 0.21% |